glutathione activator plus nac 500 mg ProCaps Laboratories Seeking Health NAC, 500 mg – GPX4 Activator 2 (CAS Number:

Yang F, Kemp CJ, Henikoff S

WADA Prohibition The World Anti-Doping Agency classification for these peptides: GLP3 likely classified under prohibited substances as a GLP-1 receptor agonist Cagrilintide status as amylin analog may fall under peptide hormone prohibitions Combined formulation would be prohibited under multiple substance categories No Therapeutic Use Exemptions (TUEs) available for either component Detection methods under development for anti-doping testing WADAs position reflects that these remain investigational agents without regulatory approval from health authorities worldwide

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: An open-label, single-arm, multicenter, pilot study Nguyen, M.T., et al (2025)

Stephen Tapanes, PhD